References
- Abu-Elmagd K. M., Fung J. J., Alessiani M., Jain A., Takaya S., Venkataramanan R., Warty V. S., Shannon W., Todo S., Tzakis A., Van Yhiel D., Starzl T. E. Strategy of FK 506 Therapy in Liver Transplant Patients: Effect of Graft Function. Transplant. Proc. 1991; 23: 2771
- Todo S., Fung J. J., Starzl T. E., Tzakis A., Demetris A. J., Kormos R., Jain A., Alessiani M., Takaya S., Shipiro R. Liver, Kidney, and Thoracic Organ Transplantation Under FK 506. Ann. Surg. 1990; 212: 295
- Jain A. B., Fung J. J., Venkataramanan R., Todo S., Alessiani M., Starzl T. E. FK 506 Dosage in Human Organ Transplantation. Transplant. Proc. 1990; 22: 23
- Moochhala S. M., Lee E. J. D., Earnest I., Wong J. Y. Y., Ngoi S. S. Inhibition of Drug Metabolism in Rat and Human Liver Microsomes by FK 506 and Cyclosporine. Transplant. Proc. 1991; 23: 2786
- Omar G., Shah I. A., Thomson A. W., Whiting P. H., Burke M. D. FK 506 Inhibition of Cyclosporine Metabolism by Human Liver Microsomes. Transplant. Proc 1991; 23: 934
- Shah I. A., Whiting P. H., Omar G., Thomson A. W., Burke M. D. Effects of FK 506 on Human Hepatic Microsomal Cytochrome P-450-dependent Drug Metabolism In Vitro. Transplant. Proc. 1991; 23: 2783
- Sattler M., Guengerich F. P., Yun C. H., Christians U., Sewing K. F. Cytochrome P-450 3A Enzymes are Responsible for Biotransformation of FK 506 and Rapamycin in Man and Rat. Drug Metab. Dispos. 1992; 20: 753
- Vincent S. H., Karanam B. V., Painter S. K., Chiu S. H. L. In Vitro Metabolism of FK 506 in Rat, Rabbit, and Human Liver Microsomes: Identification of a Major Enzymes Responsible for its Metabolism. Arch. Biochem. Biophys. 1992; 294: 454
- Waxman D. J., Attisano C., Guengerich F. P., Lapenson D. P. Human Liver Microsomal Steroid Metabolism: Identification of the Major Microsomal Steroid Hormone 6β-hydroxylase Cytochrome P-450 Enzyme. Arch. Biochem. Biophys. 1988; 263: 424
- Piekoszewski W., Chow F. S., Jusko W. J. Pharmacokinetic and Pharmacodynamic Effects of Coadministration of Methylprednisolone and Tacrolimus in Rabbits. J. Pharmacol. Exp. Ther. 1994; 269: 103
- Drewinko B., Loo T. L., Brown B., Gottlieb J. A., Freireich E. J. Combination Chemotherapy In Vitro with Adriamycin. Observations of Additive, Antagonistic, and Synergistic Effects When Used in Two-Drug Combinations on Cultured Human Lymphoma Cells. Cancer Biochem. Biophys. 1976; 1: 187
- Chou T. C. Derivation and Properties of Michaelis-Menten Type and Hill Type Equations for Reference Ligand. J. Theo. Biol. 1976; 59: 253
- Chou T. C., Tan Q. H., Sirotnak F. M. Quantitation of the Synergistic Interaction of Edatrexate and Cisplatin In Vitro. Cancer Chemother. Pharmacol. 1993; 31: 259
- Koizumi T., Kakemi M., Katayama K. Kinetics of Combined Drug Action. J. Pharmacokinet. Biopharm. 1993; 21: 593
- Eiras G., Imventarza O., Murase N., Ueda Y., Todo S., Starzl T. E., Zeevi A., Duquesnoy R. Species Differences in Sensitivity of T Lymphocytes to Immunosuppressive Effects of FK 506. Transplant. 1990; 49: 1170
- Vathsala A., Goto S., Yoshimura N., Stepkowski S., Chou T. C., Kahan B. D. The Immunosuppressive Antagonism of Low Doses of FK 506 and Cyclosporine. Transplant. 1991; 52: 121